
09/05/2025
5 Things We’re Tracking in Derm This Month
Alopecia Updates
Leqselvi™ (deuruxolitinib) is now available in the US for severe alopecia areata.
Rinvoq® (upadacitinib) shows strong results in Phase 3 trials for AA.
Mousse Sunscreens = FDA Trouble
The FDA has warned brands: mousse and foam sunscreens are not yet approved dosage forms. They’ll need new OTC drug approvals to stay on the market.
OX40 Treatment on the Horizon?
Atopic dermatitis treatment dosed just 4x a year may become a reality based on phase 3 study results for Sanofi's OX40-ligand agent, amlitelimab.
FDA Updates
Anzupgo® cream approved for chronic hand eczema, first of its kind.
Otezla gets green light to treat PsA in kids 6+.
Skincare > Surgery?
OTC skincare is booming. Dr. Chilukuri says Kris Jenner’s glow at 69 isn’t just surgery—it’s great skincare and energy-based treatments.
Follow us for more dermatology news